Pfizer Inc
Close on Oct 30, 2026Market cap $173.95BP/E 40.2Yield 5.64%
Pfizer All Other Oncology — International reported YoY by Quarter
All Other Oncology — International reported YoY (%) (%)
Pfizer All Other Oncology — International reported YoY: -37.0% in Q2 2026, down 30.0 pts from a year earlier. That is the lowest of the 30 quarters on record here.
Where the Q2 2026 figure comes from
“|| All other Oncology | 338 | 394 | (14%) | (16%) | 178 | 141 | 27% | 159 | 253 | (37%) | (40%)”
Source: Form 8-K (Earnings / Guidance Release) (pfe-6282026xex99.htm, filed 2026-08-04) ↗
Reported in Form 8-K Revenue Tables.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Pfizer All Other Oncology — International reported YoY (%), quarterly Q1 2018–Q2 2026 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/other-onc-yoy-intl
See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.